An examination of Donald Trump's consistent pattern of self-aggrandizing and often unsubstantiated claims regarding the September 11th attacks, highlighting a disregard for solemn commemoration.
An excerpt from Leah Stokes' upcoming book, "The Carbon Wave," details the pivotal 2018 moment when the Green New Deal concept entered mainstream US climate policy, fueled by grassroots activism and events like Hurricane Maria.
A new study suggests laughter therapy can be as effective as pursed-lip breathing in improving breathlessness and overall health for COPD patients. The low-cost, accessible technique offers a promising complementary approach to existing COPD care.
A major technical failure at NATS, the UK's air traffic control provider, caused widespread flight cancellations and delays on Tuesday, stranding hundreds of thousands of passengers. This marks the third significant disruption in three years, reigniting calls for NATS reform and leadership changes.
Panic announces its Playdate Season 3 Update Showcase for September 9, 2026, strategically timed just an hour after Apple's major iPhone event. The showcase will reveal game details and the release date for the anticipated third season of the unique handheld console.
Louisa Livingstone, the enigmatic model from Black Sabbath’s iconic 1970 debut album cover, has stepped into the spotlight as a musician named Indreba. After decades of a varied creative career, she's now releasing music that directly references her legendary album art, blending electronic and rock genres with a modern, AI-infused twist.
A 55-year-old Bangladeshi man presented with severe abdominal pain, later diagnosed as peritonitis caused by a live 2.2-foot eel that had entered his rectum. The rare case highlights unusual foreign body complications.
Harry Kane is a frontrunner for the 2026 Ballon d'Or, headlining a 30-player shortlist alongside fellow England stars Jude Bellingham and Declan Rice. The nominations reflect a changing guard in football, with established legends like Lionel Messi included but facing stiff competition from emerging talents and consistent performers.
The FDA has approved Etcamah (camizestrant), a new daily pill for advanced hormone-receptor-positive, HER2-negative breast cancer that has become resistant to existing treatments. Notably, its use is guided by the Guardant360 CDx blood test, which detects ESR1 mutations in circulating tumor DNA before imaging can show progression. This marks a significant advancement in personalized cancer therapy.